Hilmi Orhan - Toxicology

Author Information

Hilmi Orhan is affiliated with the Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Ege University, located in Bornova-İzmir, Turkey. He is also associated with the İzmir Biomedicine and Genome Center (İBG-İzmir) in Balcova-İzmir, Turkey.

Research Contributions

Hilmi Orhan has made significant contributions to the field of toxicology, particularly focusing on the biotransformation and metabolism of drugs and other xenobiotics. His research encompasses various aspects of drug-induced toxicity, including mitochondrial dysfunction and oxidative stress. Notably, he has investigated the toxicology of herbal medicines, bioactivation of pharmaceuticals, and the protective mechanisms against drug-induced organ injuries. His work has been published in various high-impact journals, reflecting his active engagement in advancing toxicological science.

Aliases

H Orhan, H. Orhan, Hilmi Orhan

Publication and Citation Metrics

Metric	Value
Citation Count	1659
h-index	19
Paper Count	71

Publications:

Toxicology of Herbal Medicines

DOI: 10.1201/9780203730584-12

Year: 2021

Biotransformation of Drugs and other Xenobiotics as Key Modulator of Toxicity.

DOI: 10.2174/138920022208210915160901

Year: 2021

Mitochondrial Biotransformation of Drugs and Other Xenobiotics.

DOI: 10.2174/1389200222666210628125020

Year: 2021

Metabolism and Biotransformation of Xenobiotics

DOI: 10.1201/9780203730584-3

Year: 2021

4-methylpyrazole protects against acetaminophen-induced acute kidney injury.

DOI: 10.1016/j.taap.2020.115317

Year: 2020

Bioactivation of clozapine by mitochondria of the murine heart: possible cause of cardiotoxicity.

DOI: 10.1016/j.tox.2020.152628

Year: 2020

An Expert Roundtable Discussion on Mitochondrial Toxicity

DOI: 10.1089/aivt.2019.29022.rtl

Year: 2019

Inter-individual and inter-organ variability in the bioactivation of paracetamol by human liver and kidney tissues.

DOI: 10.1016/j.etap.2018.05.015

Year: 2018

Toward consensus in the analysis of urinary 8-oxo-7 , 8-dihydro-2 ′-deoxyguanosine as a noninvasive biomarker of oxidative stress

DOI:

Year: 2017

Measurement of 8-oxo-7,8-dihydro-2′-deoxyguanosine in urine by an improved ELISA

DOI: 10.1016/J.TOXLET.2017.07.128

Year: 2017

How is Heavy Metal Poisoning Diagnosed?

Do HSPs Offer Therapeutic Potential in Toxicology?

What Are the Symptoms of Listeriosis?

How Does UV Radiation Cause Photodamage?

Is There a Safe Way to Prepare Barracuda?

What are the Key Components of an EMS in Toxicology?

How Can Communities Advocate for Change?

How Do Hazardous Additives Affect Health?

How does oil extraction impact toxicology?

How Can Chronic Toxicological Injuries Be Prevented?

Partnered Content Networks

Relevant Topics